Entera Bio Valuation

Is 5DT undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 5DT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate 5DT's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate 5DT's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 5DT?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for 5DT. This is calculated by dividing 5DT's market cap by their current preferred multiple.
What is 5DT's n/a Ratio?
n/a	0x
n/a	n/a
Market Cap	n/a

5DT key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	955.8x
Enterprise Value/EBITDA	-6.4x
PEG Ratio	n/a

Price to Book Ratio vs Peers

How does 5DT's PB Ratio compare to its peers?

The above table shows the PB ratio for 5DT vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PB	Estimated Growth	Market Cap
Peer Average	15.3x
VSC 4SC	56.1x	n/a	€61.5m
MDG1 Medigene	1.2x	-4.1%	€25.0m
HPHA Heidelberg Pharma	3.1x	-33.0%	€111.9m
2INV 2invest	1x	n/a	€59.8m
5DT Entera Bio	7.5x	-89.7%	€63.2m

Price-To-Book vs Peers: 5DT is good value based on its Price-To-Book Ratio (7.5x) compared to the peer average (15.3x).

Price to Earnings Ratio vs Industry

How does 5DT's PE Ratio compare vs other companies in the DE Biotechs Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	36.2%
	n/a	n/a	n/a

Fetching data

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	36.2%
	n/a	n/a	n/a

No more companies

Price-To-Book vs Industry: 5DT is expensive based on its Price-To-Book Ratio (7.5x) compared to the European Biotechs industry average (2.4x).

Price to Book Ratio vs Fair Ratio

What is 5DT's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

5DT PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio	7.5x
Fair PB Ratio	n/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate 5DT's Price-To-Book Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.